Key result
In chick embryos, the temporal dynamics of the nitric oxide source switches from nitrite reductase to nitric oxide synthase during early vasculogenesis, driven by hypoxia.
Why the study?
Endothelium-derived nitric oxide is a mediator of angiogenesis, but nitric oxide-mediated regulation of vasculogenesis remains largely unknown.
This study demonstrates that early vasculogenesis is regulated by a temporal switch in nitric oxide production from nitrite reductase to nitric oxide synthase under hypoxic conditions.
Hypothesis-generating in avian embryos; leaves open relevance of NO source switching to mammalian or human vasculogenesis.
Endothelium-derived nitric oxide (NO) is a mediator of angiogenesis. However, NO-mediated regulation of vasculogenesis remains largely unknown. In the present study, we show that the inhibition of NO significantly attenuated endothelial migration, ring formation, and tube formation. The contribution of nitric oxide synthase (NOS) enzymes during early vasculogenesis was assessed by evaluating endothelial NOS (eNOS) and inducible NOS (iNOS) mRNA expression during HH10-HH13 stages of chick embryo development. iNOS but not eNOS was expressed at HH12 and HH13 stages. We hypothesized that vasculogenic events are controlled by NOS-independent reduction of nitrite to NO under hypoxia during the very early phases of development. Semi-quantitative polymerase chain reaction analysis of hypoxia-inducible factor-1α (HIF-1α) showed higher expression at HH10 stage, after which a decrease was observed. This observation was in correlation with the nitrite reductase (NR) activity at HH10 stage. We observed a sodium nitrite-induced increase in NO levels at HH10, reaching a gradual decrease at HH13. The possible involvement of a HIF/NF-κB/iNOS signaling pathway in the process of early vasculogenesis is suggested by the inverse relationship observed between nitrite reduction and NOS activation between HH10 and HH13 stages. Further, we detected that NR-mediated NO production was inhibited by several NR inhibitors at the HH10 stage, whereas the inhibitors eventually became less effective at later stages. These findings suggest that the temporal dynamics of the NO source switches from NR to NOS in the extraembryonic area vasculosa, where both nitrite reduction and NOS activity are defined by hypoxia.
No takes yet. Share an insight, caveat, or question.
Rajendran et al. (2021) studied Early vasculogenesis. Nitric oxide (NO) inhibition and sodium nitrite was evaluated on Endothelial migration, ring formation, tube formation, and NO levels. In chick embryos, the temporal dynamics of the nitric oxide source switches from nitrite reductase to nitric oxide synthase during early vasculogenesis, driven by hypoxia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: